Overexpression of biotin synthase and biotin ligase is required for efficient generation of sulfur-35 labeled biotin in E. coli
© Delli-Bovi et al; licensee BioMed Central Ltd. 2010
Received: 13 May 2010
Accepted: 11 October 2010
Published: 11 October 2010
Biotin is an essential enzyme cofactor that acts as a CO2 carrier in carboxylation and decarboxylation reactions. The E. coli genome encodes a biosynthetic pathway that produces biotin from pimeloyl-CoA in four enzymatic steps. The final step, insertion of sulfur into desthiobiotin to form biotin, is catalyzed by the biotin synthase, BioB. A dedicated biotin ligase (BirA) catalyzes the covalent attachment of biotin to biotin-dependent enzymes. Isotopic labeling has been a valuable tool for probing the details of the biosynthetic process and assaying the activity of biotin-dependent enzymes, however there is currently no established method for 35S labeling of biotin.
In this study, we produced [35S]-biotin from Na35SO4 and desthiobiotin with a specific activity of 30.7 Ci/mmol, two orders of magnitude higher than previously published methods. The biotinylation domain (PfBCCP-79) from the Plasmodium falciparum acetyl-CoA carboxylase (ACC) was expressed in E. coli as a biotinylation substrate. We found that overexpression of the E. coli biotin synthase, BioB, and biotin ligase, BirA, increased PfBCCP-79 biotinylation 160-fold over basal levels. Biotinylated PfBCCP-79 was purified by affinity chromatography, and free biotin was liberated using acid hydrolysis. We verified that we had produced radiolabeled biologically active [D]-biotin that specifically labels biotinylated proteins through reuptake in E. coli.
The strategy described in our report provides a simple and effective method for the production of [35S]-biotin in E. coli based on affinity chromatography.
Biotin, or vitamin H, was first identified as a yeast growth factor over 100 years ago and was subsequently isolated from egg yolk and liver. It is an essential cofactor for a small family of enzymes that catalyze carboxylation and decarboxylation reactions, in which biotin serves as a covalent attachment site for CO2. The number of biotinylated proteins varies from one to five in different organisms. Biotin-dependent enzymes include acetyl-CoA carboxylase, pyruvate carboxylase, propionyl-CoA carboxylase, methylcrotonyl-CoA carboxylase, geranoyl-CoA carboxylase, oxaloacetate decarboxylase, methylmalonyl-CoA decarboxylase, transcarboxylase and urea amidolyase. These enzymes participate in central metabolic processes such as gluconeogenesis, lipogenesis, amino acid metabolism and energy transduction. The most widespread biotin-dependent enzyme is acetyl-CoA carboxylase (ACC), which catalyzes the ATP-dependent transfer of a carboxyl group from carbonate to acetyl-CoA to form malonyl-CoA, in the first committed step of fatty acid biosynthesis.
ACC is the only biotinylated enzyme in Escherichia coli, and it exists as a complex of four proteins: biotin carboxylase (BC), carboxyl transferase alpha and beta chains (CT), and biotin carboxy carrier protein (BCCP). The BC subunit is responsible for transferring a carboxyl group from a substrate (carbonate) to the biotin prosthetic group, which is covalently attached to a conserved lysine in the BCCP subunit. The CT serves to transfer the carboxyl group from biotin to acetyl-CoA, forming malonyl-CoA. Biotin is attached to BCCP by a dedicated biotin protein ligase, BirA. This enzyme catalyzes the ATP-dependent formation of an amide linkage between the carboxyl group of biotin and the ε-amino group of a specific lysine residue in BCCP. The primary structure of biotinylation domains exhibits a high degree of similarity across species. The biotinylated lysine residue occurs in a conserved AMKM tetrapeptide, and a minimum of 75-80 residues surrounding this motif are required for recognition by BirA. Biotin protein ligases show significant cross reactivity between species, i.e. bacterial ligases biotinylate mammalian apo-proteins, and vice versa.
E. coli can scavenge biotin from the environment, or synthesize it de novo from a pimeloyl-CoA precursor. The enzymes of the biosynthetic pathway are encoded by the bio operon (bioABCFD). The final step, insertion of sulfur into desthiobiotin to form biotin, is catalyzed by biotin synthase (BioB). This enzyme contains two iron-sulfur clusters, a [4Fe-4S] cluster common to all radical SAM (S-adenosyl-L-methionine) enzymes which facilitates the reductive cleavage of SAM, and a [2Fe-2S] cluster which donates the sulfur atom to desthiobiotin.
The metabolic origins of biotin and its attachment to proteins have been tracked using carbon, sulfur and hydrogen isotopes[16–18]. Currently [3H]-biotin is commercially available, but is not feasible to use as a metabolic label in some systems due to the low sensitivity of 3H. Previous attempts have been made to label biotin with 35S using intact cells of Saccharomyces cerevisiae, Aspergillus niger and Rhodotorula glutinis, however these attempts were hampered by poor yield, low specific activity of biotin, or the predominance of oxidized biotin species.
Results and Discussion
Expression of a biotin-domain in E. coli
Biotin biosynthesis in E. coli is a tightly regulated process, and results in about 200 molecules of protein-bound biotin per cell. To increase the yield of biotin production in E. coli, we expressed a biotin carrier protein, which contained an affinity tag to aid in its purification. Both E. coli and the malaria parasite Plasmodium falciparum encode a single biotinylated protein in their genome, the acetyl-CoA carboxylase (ACC). In E. coli, the enzyme exists as a complex of four proteins, while in P. falciparum, the ACC is a single large polypeptide. Despite the difference in structure, the domains of the P. falciparum ACC are homologous to the protein subunits of the E. coli ACC complex. Biotin is conjugated to a particular lysine in the biotin carboxy carrier protein (BCCP) domain. We selected the P. falciparum BCCP as a biotinylation substrate because it does not contain cysteine residues, which would incorporate the 35S label and complicate the purification and quantification of radiolabeled biotin. The E. coli BCCP contains a single cysteine at amino acid 116, which is only four amino acids away from the conserved AMKM biotinylation motif. Therefore, mutation of this residue may interfere with the folding of the protein or the biotinylation reaction. The ~80-residue biotinylation sites of the BCCP orthologs share 48% sequence similarity, so we expected that the E. coli biotin ligase would recognize and biotinylate the P. falciparum protein in vivo.
PfBCCP-79 was expressed as a GST fusion protein in BL21-Star(DE3) cells, and purified by affinity chromatography on a glutathione-Sepharose column, yielding 110 mg of protein from 1 L of culture (Figure 2B, lane 1). The fusion protein was cleaved in vitro by TEV protease (lane 2) and the sample was reapplied to the column to remove free GST. Our final sample did not contain any contaminants visible by Coomassie blue staining, except for a faint band corresponding to free GST (lane 3). Purified PfBCCP-79 was concentrated to 1.2 g/L, and used for the production of specific antisera in rabbits.
Because the GST fusion protein is not ideal for labeling with 35S, due to the presence of multiple cysteines that would incorporate the radiolabel, we also expressed PfBCCP-79 with an N-terminal six-histidine tag from plasmid pTDe010. pTDe010 encodes His6-tagged PfBCCP-79 under control of a T7 promoter, with a kanamycin resistance cassette and a pMB1 origin of replication. His6-tagged PfBCCP-79 was expressed in BL21-Star(DE3) cells, and purified on a metal chelate column charged with NiCl2, yielding 90 mg of protein from 2 L of culture (Figure 2B, lane 4). These data demonstrate that PfBCCP-79 is soluble, expressed at high levels, and can be purified with high yield by affinity chromatography.
Biotinylation of PfBCCP-79
In order to evaluate whether PfBCCP-79 is a valid biotin carrier for the purification of [35S]-biotin from E. coli, we tested whether it is biotinylated efficiently by the E. coli biotin ligase, BirA. It has been shown that EcBCCP is not efficiently biotinylated when it is overexpressed, unless it is coexpressed with BirA. In order to assess whether this was the case for PfBCCP-79, we measured biotinylation levels of PfBCCP-79 in cells that overexpress BirA from plasmid pCY216, which encodes the E. coli birA gene under control of an arabinose-inducible promoter in a chloramphenicol resistant plasmid. We considered expressing a cognate biotin ligase from P. falciparum, however, malaria parasites appear to encode two BirA paralogs (PF10_0409 and PF14_0573) and it is not clear which enzyme would be the appropriate ligase for PfBCCP-79. We therefore chose to rely on the fact that there is a high level of cross-reactivity between biotin ligases and biotinylated proteins from divergent species.
We found that overproduction of BirA did not appear to effect the efficiency of PfBCCP-79 biotinylation (Figure 3, lane 1). This may be explained by the transcriptional regulation function of BirA. When BCCP is fully saturated with biotin the BirA-biotinyl-AMP intermediate accumulates, promoting the cooperative dimerization of BirA; this complex binds to the biotin operator and represses transcription of biotin biosynthetic genes[25, 26]. In this way, biotin synthesis and protein biotinylation are tightly coupled, and there is little free intracellular biotin. Overexpression of BirA may increase the amount of the repressor species, and thus shut down biotin biosynthesis. This hypothesis implies that the dynamics of biotinylation differ between the E. coli and P. falciparum substrates, that is, if the efficiency of PfBCCP-79 biotinylation is significantly slower than that of EcBCCP, the BirA-biotinyl-AMP repressor will accumulate even in the presence of excess apo-PfBCCP-79. The fact that EcBCCP biotinylation levels did not change between different conditions supports this model.
To circumvent this problem, we coexpressed PfBCCP-79 with both BirA and the biotin synthase, BioB. BioB catalyzes the final step in the biotin biosynthetic pathway, the insertion of sulfur into desthiobiotin to form biotin. We measured PfBCCP-79 biotinylation in cells expressing BioB from plasmid pSPr059, which encodes the E. coli bioB gene under control of the λPL/tetO promoter in an ampicillin resistant plasmid. We found that coexpression of PfBCCP-79 with BioB alone increased biotinylation 16-fold over the level seen with BirA alone (Figure 3, lane 2), while coexpression with both BioB and BirA resulted in an additional 10-fold increase in biotinylation (lane 4).
BioB donates sulfur from a [2Fe-2S] cluster to desthiobiotin in a suicide mechanism. If regeneration of the iron-sulfur cluster is a limiting step in this pathway, then biotinylation efficiency can be increased by facilitating the remetalation of BioB. The Isc (Iron Sulfur Cluster) proteins from Azotobacter vinelandii comprise the iron-sulfur cluster biogenesis pathway in this organism and have been shown to increase the yield of properly metalated biotin synthase when expressed in E. coli. We tested the effect on biotinylation levels when we added plasmid pDB1282 to our cell line, which encodes the essential genes of the Isc operon from A. vinelandii (iscS, iscU, iscA, hscB, hscA and fdx) under control of an arabinose-inducible promoter with an ampicillin resistance cassette. We found that overproduction of PfBCCP-79 with the AvIsc proteins, either alone or in combination with BirA, did not have a significant effect on biotinylation levels (Figure 3, lanes 3 and 5). These results indicate that remetalation of endogenous BioB by the Isc proteins was less effective in promoting biotin synthesis than overexpression of BioB, and thus the formation of iron-sulfur clusters on BioB is not a limiting step in biotin synthesis.
An alternative explanation is that the AvIsc proteins are not expressed at sufficient levels to affect PfBCCP-79 biotinylation. These experiments were carried out in minimal media containing glucose as the carbon source. Since glucose inhibits the uptake of pentose sugars such as arabinose, the induction of BirA and the AvIsc proteins could be affected by this medium. We conducted the experiments shown in Figure 3 substituting glucose with 0.4% glycerol and found that biotinylation in cells expressing BirA tripled, however, there was no effect in cells expressing the AvIsc proteins, and only a modest increase of 8% in cells expressing both BirA and BioB (data not shown). Thus, removing glucose from the medium does slightly increase biotinylation due to increased expression of BirA, but not AvIsc proteins. Although glucose does affect the expression of BirA by arabinose, the long low temperature induction used in our experiments largely compensates for this effect. Indeed, we observe protein bands by SDS-PAGE corresponding to BirA and certain Isc proteins which are only present after induction with arabinose (data not shown).
Loading samples ten times more concentrated showed that there was some biotinylated PfBCCP-79 under all the conditions tested (Figure 3, middle panel). Western blot analysis using PfBCCP antiserum showed that the protein is expressed at similar levels in all the cultures (Figure 3, lower panel). Together, these results indicate that PfBCCP-79 can be expressed in E. coli, and is biotinylated by the E. coli biotin ligase. We can increase the yield of biotin production by overexpressing key enzymes of the biosynthetic pathway. We bypassed the negative feedback loop that regulates the biotin operon by overexpressing the biotin synthase, BioB, under a constitutive promoter, and supplementing the culture with the BioB substrate, desthiobiotin. We found that it was also necessary to overexpress the biotin ligase, BirA, for efficient biotinylation of PfBCCP-79.
Purification of PfBCCP-79
By comparing the flow through (FT2) and elution fractions (E1/E2) from the avidin column, we estimated that 40% of the PfBCCP-79 from the metal chelate column was binding to the avidin column. This suggests that in vivo less than half of the protein is biotinylated, or alternatively, that biotinylated protein did not bind to the column for some reason. To address this question, we transferred the proteins to nitrocellulose membrane for affinity blotting using streptavidin-HRP. No biotinylated proteins were detected in FT2, confirming that the unbound PfBCCP-79 was not biotinylated (Figure 4B). This experiment also revealed that approximately half (49%) of the biotinylated protein did not bind to the metal chelate column (Figure 4B, lane 2), perhaps due to slow kinetics of binding. To address this question, we reapplied the flow through to a clean metal chelate column, and observed that no additional PfBCCP-79 bound the column (data not shown). Thus, this protein cannot bind to the column, probably due to degradation of the affinity tag. Indeed, the lower band near 6 kDa in FT1 is likely a degradation product of biotinylated PfBCCP-79. One way to address this problem, and increase the yield from the purification, would be to tag the protein on both the N- and C-termini. We estimated that 18% of the PfBCCP-79 present in the cell lysate was recovered in the elution. Overall, these data show that PfBCCP-79 is a valid biotinylation substrate in E. coli and can be purified from cell lysate by affinity chromatography.
Production of [35S]-biotin
We also analyzed these samples using anti-PfBCCP antiserum (Figure 5C). The antiserum detected the same ~6 kDa band in FT1 that we observed in the previous experiment. This indicates that the fragment is a degradation product of the PfBCCP-79 fusion protein, and not derived from the endogenous E. coli BCCP. This band is also present in the purified sample (E1), suggesting that some degradation occurs during the purification process. We carried out densitometry analysis of this western blot to determine the proportion of PfBCCP-79 present in each sample, and our results were consistent with those from the previous experiment. We estimated that 56% of the protein did not bind the MC column (versus 49% in the previous experiment), and was collected in FT1. An additional 6% was removed in the first wash with 30 mM imidazole. The remaining unbiotinylated PfBCCP-79 was collected in the flow through from the avidin column, which amounted to 18% of total protein. Our purified sample contained 21% of the starting amount of PfBCCP-79 in the cell lysate (compared to 18% in the previous experiment), corresponding to 9.9 μg of PfBCCP-79. We also repeated our calculation of the biotinylation efficiency based on these results. We estimated that 54% of the total PfBCCP-79 was biotinylated, which was higher than our previous estimate of 40%. This difference may be due to differences between the two experiments, or error associated with comparing results between SDS-PAGE and western blot images.
Verification and quantification of biologically active [35S]-biotin in E. coli
The hydrolysate containing [35S]-biotin may be used directly for biotin labeling experiments, as the only source of radioactivity in the sample is from biotin. However, in some cases it may be desirable to further purify biotin from the hydrolyzed protein and other material in the sample. Silica gel flash chromatography or high performance liquid chromatography (HPLC) would be most suitable for this purpose.
We developed an assay to quantify the amount of biotin in the sample, using the same ΔbioB E. coli strain. If this strain is supplemented with known concentrations of biotin, it will grow at a rate proportional to the biotin in the culture, over a small range of biotin concentrations (between 0 pM and 400 pM). Based on the biotin concentrations that limited growth, we estimated that about 250 molecules of biotin are required per E. coli cell, in close agreement with a previous estimation of 200 molecules per cell. These cultures were used to construct a standard growth curve (Figure 6C). Cultures supplemented with serial dilutions of the hydrolysate were grown in parallel, and the optical density of these cultures was compared to the standard curve in order to determine the concentration of biotin in the original sample. We found that a 2 mL culture of ΔbioB E. coli supplemented with 5 μl of PfBCCP-79 hydrolysate grew to an OD600 of 0.62. We estimated that this culture contained 185 pM biotin based on comparison to the biotin standard curve depicted in Figure 6C. Thus, we obtained 37 pmol of biotin from the original 10 mL E. coli culture, and the specific activity of [35S]-biotin produced by our method is 30.7 Ci/mmol. In a previous attempt to label biotin with 35S in Aspergillus niger, Shimada and coworkers reported a specific activity of only 0.41 Ci/mmol. We have thus achieved an increase in sensitivity of two orders of magnitude, which is a significant advantage for the detection of biotinylated molecules that are usually present at low intracellular concentrations. Although antibodies are available that can measure biotin, radiolabeled biotin is a more sensitive probe, and can be more accurately quantified. In addition, only radiolabeled biotin can track a specific population of biotin, and differentiate between newly synthesized biotin and biotin that is scavenged from the growth media.
We developed a simple and effective strategy for the production of [35S]-biotin in E. coli. We have shown that a 79-residue fragment of the P. falciparum BCCP functions as a biotinylation substrate in vivo, and that the biotinylation efficiency of PfBCCP-79 can be enhanced by overproduction of the E. coli biotin synthase, BioB, and biotin ligase, BirA. Biotinylated PfBCCP-79 was purified from whole cell lysate using affinity chromatography, and free biotin was liberated by acid hydrolysis. We measured the reuptake of biotin in E. coli in order to quantify the biotin in the sample, and to verify that we had produced biologically active, radiolabeled [D]-biotin, which specifically labels cellular proteins.
Plasmid constructs for expression of PfBCCP
The expression vector pGEXT was constructed from pGEX-4T-3 (GE Healthcare) by replacing the sequence encoding the thrombin cleavage site (beginning at base 918) with that of the tobacco etch virus (TEV) protease. This was done with the QuikChange site-directed mutagenesis kit (Stratagene), using primers TEV1, 5'-GGTGGCGACCATCCTCCAAAATCGGATgaaaacctgtattttcagggcGGATCCCCGAATTCCCGGGTC-3' and TEV2, 5'-GACCCGGGAATTCGGGGATCCgccctgaaaatacaggttttcATCCGATTTTGGAGGATGGTCGCCACC-3' (TEV cleavage site shown in lower case). The resulting vector, pGEXT, produces a glutathione S-transferase (GST) fusion protein which can be cleaved by TEV protease.
The biotin carboxy carrier protein (BCCP) domain (residues 1156-1369) of the P. falciparum acetyl-CoA carboxylase (ACC) gene [GenBank:XM_001348802; PlasmoDB:PF14_0664] was amplified by PCR from cDNA of P. falciparum 3D7 erythrocyte stages, using primers BCCP1, 5'-GGTGGTGGATCCTTATGTGCTACCATATTTAAACTATTAATATATTTTATG-3' and BCCP2, 5'-GGTGGTCTCGAGTTATTCTATTATTCCTAATAAATCTCCTATTTTAATAATTG-3'. The PCR product was digested with BamHI and XhoI (underlined) and ligated into the pGEXT vector digested with the same endonucleases, generating plasmid pMSp038. The resulting fusion protein (PfBCCP) contained the entire BCCP domain with an N-terminal GST tag. In order to test for solubility of the fusion protein, 100 ml cultures were grown to an OD600 of 0.6, protein expression was induced with IPTG, and the cultures were incubated for an additional three hours at 37°C. Cells were lysed, and whole cell lysate was centrifuged to separate the soluble and insoluble fractions. The PfBCCP fusion protein was found in the insoluble fraction. A second construct was designed (PfBCCP-79) based on the biotinylation domain found in the crystal structure of the E. coli BCCP [PDB:1BDO]. Nucleotides encoding ACC residues 1291-1369 were amplified from pMSp038 using primers BCCP3, 5'-GGTGGTGGATCCGATAATATTTTCATACCTAATGTTAGGAATCC-3' and BCCP2, digested with BamHI and XhoI and ligated into the pGEXT vector, generating plasmid pTDe003. Expression tests using pTDe003 indicated that the resulting GST fusion protein was soluble. PfBCCP-79 was purified from E. coli (see below) and used for the generation of specific antisera in rabbits.
Purification of PfBCCP-79 for generation of rabbit antisera
Plasmid pTDe003, encoding GST-tagged PfBCCP-79, was transformed into BL21-Star(DE3) cells (Invitrogen) previously transformed with the pRIL plasmid isolated from BL21-CodonPlus(DE3) cells (Stratagene). pRIL encodes rare tRNAs that aid in the expression of P. falciparum proteins in E. coli. Cells were grown to an OD600 of 0.8 in LB medium at 37°C, and then protein expression was induced with 0.4 mM IPTG and the cultures were maintained at 20°C for 10 hrs. Cells were harvested by centrifugation at 4,000 g for 20 min at 4°C followed by resuspension in 20 mL of lysis buffer (phosphate buffered saline (PBS) solution pH 7.5, 1 mg/mL lysozyme, 2.5 μg/mL DNAse I, 10 mM PMSF, 10 mM DTT) per liter of cell culture. The resuspended cell mixture was sonicated, and then cleared by centrifugation at 30,000 g for 20 min at 4°C. Cleared supernatant was loaded on a GSTrap™ Fast-Flow chromatography column (GE Healthcare) equilibrated in PBS pH 7.5. After washing with 5 column volumes of PBS, GST fusion protein was eluted with 5 mM reduced glutathione in equilibration buffer. Fractions containing fusion protein were pooled and digested with 10 μg/ml TEV protease for 6 days at 4°C. The protein sample was dialyzed to remove glutathione and then re-applied to the GSTrap™ FF column to remove the liberated GST. The purified protein was concentrated to 1.185 g/L with a 5000 MW cutoff concentrator (Vivascience) and sent to Cocalico Biologicals, Inc. for production of specific antisera in rabbits.
Polyclonal antibodies were raised against PfBCCP-79 according to the standard immunization protocol specified by Cocalico Biologicals, Inc. Prebleeds from four rabbits were screened for cross-reactivity to P. falciparum and human red blood cell antigens by western blot analysis. The two rabbits that were least reactive were selected for inoculation with 100 μg purified PfBCCP-79. The rabbits were boosted with 50 μg antigen on days 14, 21 and 49 after initial inoculation. Test bleeds were performed on days 35 and 56, and were tested for reactivity to the PfBCCP-79 antigen by western blot analysis. Production bleeds were performed on days 63 and 84, and the rabbits were exsanguinated on day 91. These antisera were used without further purification for western blot analysis, as described below.
Plasmid constructs for expression of biotinylated PfBCCP-79
For labeling with 35S, the GST fusion protein is undesirable due to the presence of multiple cysteine residues that will incorporate the label. To address this problem, we constructed a plasmid expressing PfBCCP-79 with a six-histidine tag. The PfBCCP-79 gene sequence was amplified from pTDe003 using primers BCCP4, 5'-GGTGGTCATATGGATAATATTTTCATACCTAATGTTAGGAATCC-3' and BCCP5, 5'-GGTGGTGAATTCTTATTCTATTATTCCTAATAAATCTCCTATTTTAATAATTG-3', digested with NdeI and EcoRI (underlined) and ligated into the pET28a vector (Invitrogen), generating plasmid pTDe010. This plasmid contains a kanamycin resistance cassette and a pMB1 origin of replication, and produces His-tagged PfBCCP-79 under control of a T7 promoter.
Plasmid pDB1282 was a gift from Dennis Dean at Virginia Polytechnic Institute and State University (Virginia Tech). Plasmid pDB1282 contains the Isc (Iron-Sulfur Cluster) operon from Azotobacter vinelandii, which is required for iron-sulfur cluster biogenesis in this organism. The Azotobacter vinelandii Isc operon is composed of the genes iscR, iscS, iscU, iscA, hscB, hscA, fdx and iscX. The essential genes of this cluster (iscS, iscU, iscA, hscB, hscA and fdx) were cloned into a variant of the pARA13 expression vector to form pDB1282. Sequencing of the 5' and 3' splice sites suggests that the Isc operon was restricted with BspHI and ligated into the unique NcoI site of pAra13. Interestingly, pDB1282 contains the seven complete genes from iscS to iscX as well as about 200 nucleotides of a downstream nucleoside-diphosphate kinase (ndk). This plasmid contains an ampicillin resistance cassette and produces the Isc genes under control of an arabinose-inducible promoter.
Plasmid pCY216 [GenBank:AAD22470.1] was a gift from John Cronan at the University of Illinois at Urbana-Champaign. It was modified from the pARA13 expression vector, and encodes E. coli BirA under control of an arabinose-inducible promoter in a chloramphenicol resistance plasmid containing a p15a origin of replication.
Plasmid pRK586 was modified to produce the E. coli biotin synthase (BioB). The bioB gene was amplified from K-12 E. coli with the primers BioB1, 5'-GGTGGTGGTACCATGCATATGGCTCACCGCCCACGCTG-3', and BioB2, 5'-GGTGGTGGATCCGCGGCCGCTCATAATGCTGCCGCGTTGTAATATTC-3'. The resulting amplicon, which contained 5' KpnI/NsiI sites and 3' NotI/BamHI sites (underlined), was digested with KpnI and BamHI and ligated into pRK586 digested with the same endonucleases. The resulting plasmid, pSPr058, was digested with BclI and SacI to excise the kanamycin resistance gene (encoding aminoglycoside 3'-phosphotransferase). Primers Amp1, 5'-GGTGGTTGATCAGCCTTTTTGCGTTTCTACAAACTC-3' and Amp2, 5'-GGTGGTGAGCTCTTACCAATGCTTAATCAGTGAGGC-3' were used to amplify the ampicillin resistance gene (encoding β-lactamase) and 118 upstream bases from plasmid pDB1282. The resulting amplicon was digested with BclI and SacI (underlined) and ligated into the pSPr058 fragment described above. The resulting plasmid, pSPr059, encodes BioB under control of the λPL/tetO promoter in an ampicillin resistant plasmid containing a pSC101 origin of replication.
In vivo biotinylation of PfBCCP-79 and western blotting
The methionine auxotroph E. coli strain B834(DE3) (Novagen) was transformed with plasmid pTDe010 (encoding PfBCCP-79), in combination with either pSPr059 (encoding BioB), pCY216 (encoding BirA) or pDB1282 (encoding the AvIsc proteins). Transformed cells were grown to an OD600 of 0.8 at 37°C with the appropriate antibiotics in minimal medium composed of sulfur-free minimal E medium (0.83 mM MgCl2, 9.5 mM citric acid, 58 mM K2HPO4, 29.7 mM NH4Cl, 16.7 mM NaH2PO4) supplemented with 0.4% (w/v) glucose, 100 μM FeCl3, and 2 mM methionine. Protein expression was induced with 0.4 mM IPTG and 0.025% arabinose, and the BioB substrate desthiobiotin (Sigma-Aldrich) was added at a concentration of 1 mM. Cells were grown for 10 hours at 20°C. Cultures were normalized based on their cell density, and equal amounts of cells were harvested by centrifugation at 16,000 g for 5 min in 1.5 ml Eppendorf tubes. Cell pellets were lysed in NuPAGE sample buffer (Invitrogen) and vortexed to shear genomic DNA. For western blot analysis, proteins were separated by sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) on 4-12% bis-tris acrylamide gradient gels. The gels were blotted onto 0.2 μm nitrocellulose membranes (Invitrogen) for 120 min at 5 V using a Semi-Dry transfer cell (BioRad). Membranes were blocked in 5% non-fat dry milk (Carnation) in PBS, washed in PBS, and probed with 1:4,000 streptavidin-HRP, ultrasensitive (Sigma-Aldrich). After PBS washes, HRP was detected using the Supersignal® West Pico chemiluminescent kit (Pierce). Membranes were then stripped using 4% (w/v) trichloroacetic acid (TCA), blocked as before, washed in PBS, and probed with rabbit antiserum specific for PfBCCP-79 (1:4,000). After PBS washes, the blot was probed with 1:5,000 donkey anti-rabbit immunoglobulin antibody conjugated to horseradish peroxidase (GE Healthcare). Excess antibody was removed with PBS, and HRP was detected using the chemiluminescent kit.
Expression and purification of [35S]-biotin-PfBCCP-79
For radiolabeling studies, the methionine auxotroph E. coli strain B834(DE3) (Novagen) was transformed with plasmids pTDe010, pSPr059 and pCY216. Cells were cultured at 37°C in 10 mL sulfur-free minimal medium (described above). When the culture reached an OD600 of 0.8, expression of PfBCCP-79 and BirA were induced with 0.4 mM IPTG and 0.025% arabinose, respectively. The culture was transferred to 20°C, and after one hour, 1 mCi Na35SO4 (American Radiolabeled Chemicals, 10 mCi/ml) and 1 mM desthiobiotin were added. The culture was maintained at 20°C for an additional 10 hours. Cells were then harvested by centrifugation for 20 min at 3,000 g and frozen at -20°C for later purification.
Cell pellets were lysed at room temperature for 10 min in 1 mL BugBuster (Novagen) supplemented with 1 mg/mL lysozyme and 2.5 μg/mL DNAseI. The cell lysate was cleared by centrifugation for 5 min at 16,000 g and applied to a 1 ml HiTrap Metal Chelate HP Column (GE Healthcare) equilibrated with Buffer A (20 mM Na/K phosphate pH 7.5). The column was washed with 7 mL Buffer A, and the combined flow through was collected and labeled FT1. The column was washed with 5 mL 30 mM imidazole in Buffer A (W1), followed by 5 mL 1 M NaCl in Buffer A (W2), and 5 mL 1% Triton X-100 in Buffer A (W3). The metal chelate column was then connected to a 4.6 mm × 100 mm PEEK™column (Applied Biosystems) packed with 1.7 mL SoftLink™ Soft Release Avidin Resin (Promega), and bound proteins were eluted from the metal chelate column with 5 mL 400 mM imidazole in Buffer A (FT2). Both columns in tandem were washed with 8 mL Buffer A (W4), and then the metal chelate column was removed. Bound protein was eluted from the avidin column in 4 mL 50 mM glycine pH 2.9 (E1). 400 μl 1 M Tris was added to the collection tube prior to eluting to prevent damage over time from the low pH of the elution buffer.
The purified biotinylated PfBCCP-79 protein was precipitated by adding 100% (w/v) TCA to a final concentration of 10%, and centrifuging for 15 min at 16,000 g. The resulting protein pellet was resuspended in 200 μL 5 M HCl and incubated at 95°C for 8 hours. One μL 1 g/L phenol red was added as a pH indicator, and the resulting hydrolysate was buffered by adding 50 μL 1 M K2HPO4, and neutralized by adding 10 M NaOH until the pH indicator turned pink.
Verification and quantification of biologically active [35S]-biotin in E. coli
A biotin bioassay was developed using a biotin auxotroph E. coli strain in which the biotin synthase (bioB) gene had been replaced with a kanamycin resistance cassette (National BioResource Project (NIG, Japan):Keio JW0758). These cells were grown to full density in LB with 50 μg/mL kanamycin. To deplete biotin levels prior to the assay, 1 μL of the LB culture was added to 4 mL biotin-free minimal medium composed of minimal E medium (0.81 mM MgSO4, 9.5 mM citric acid, 58 mM K2HPO4, 7.4 mM (NH4)2SO4, 16.7 mM NaH2PO4) supplemented with 0.4% (w/v) glucose, 30 μM FeSO4, and 50 μg/mL kanamycin. This culture grew to full density over a one day period at 37°C, and 1 μL of this culture was used to start a second 4 mL culture in biotin-free minimal medium. This culture achieved a lower density, presumably due to the 16,000,000 fold dilution of biotin from the original LB culture. For the bioassay, 2 μL of the biotin depleted culture was added to 2 mL biotin-free minimal medium supplemented with known concentrations of biotin. Assay cultures were grown at 37°C for 16 hours, after which the optical density was measured at 600 nm. These cultures were used to construct a standard growth curve. Parallel cultures were supplemented with serial dilutions of PfBCCP-79 hydrolysate. Cell densities of cultures supplemented with the hydrolysate were compared with the standard curve in order to quantify the biologically active biotin in the hydrolysate. In order to detect [35S]-biotin incorporation into the E. coli BCCP protein, cells were harvested and proteins were separated by SDS-PAGE, transferred to nitrocellulose membrane and exposed to autoradiography film.
Plasmid pCY216 was a gift from John Cronan at the University of Illinois at Urbana-Champaign. Plasmid pDB1282 was a gift from Dennis Dean at Virginia Polytechnic Institute and State University (Virginia Tech). The biotin auxotroph E. coli strain Keio JW0758 was provided by the National BioResource Project (NIG, Japan). Plasmid pRK586 was a gift from David Waugh at the National Cancer Institute. The authors thank Caelin Potts, Jolyn Gisselberg and Swetha Velivela for reagents and technical assistance. This work was supported by the National Institutes of Health (R01 AI065853), the Johns Hopkins Malaria Research Institute and the Bloomberg Family Foundation.
- Wildiers E: Nouvelle substance indispensable au developpement de la levure. La Cellule. 1901, 18: 313-332.
- Koegl F, Toennis B: Uber das bios-problem: Darstellung von krystallisiertem Biotin aus eigelb. Z Physiol Chem. 1936, 242: 43-73.View Article
- du Vigneaud V, Hofmann K, Melville DB, Gyorgy P: Isolation of Biotin (Vitamin H) from Liver. J Biol Chem. 1941, 140: 643-651.
- Chapman-Smith A, Cronan JE: The enzymatic biotinylation of proteins: a post-translational modification of exceptional specificity. Trends Biochem Sci. 1999, 24: 359-363. 10.1016/S0968-0004(99)01438-3.View Article
- Cronan JE, Reed KE: Biotinylation of proteins in vivo: a useful posttranslational modification for protein analysis. Methods Enzymol. 2000, 326: 440-458. full_text.View Article
- Jitrapakdee S, Wallace JC: The biotin enzyme family: conserved structural motifs and domain rearrangements. Curr Protein Pept Sci. 2003, 4: 217-229. 10.2174/1389203033487199.View Article
- Cronan JE, Waldrop GL: Multi-subunit acetyl-CoA carboxylases. Prog Lipid Res. 2002, 41: 407-435. 10.1016/S0163-7827(02)00007-3.View Article
- Alberts A, Vagelos PR: The Enzymes. 1972, New York: Academic Press, 3
- Fall RR, Vagelos PR: Biotin carboxyl carrier protein from Escherichia coli. Methods Enzymol. 1975, 35: 17-25. 10.1016/0076-6879(75)35133-1.View Article
- Guchhait RB, Polakis SE, Dimroth P, Stoll E, Moss J, Lane MD: Acetyl coenzyme A carboxylase system of Escherichia coli. Purification and properties of the biotin carboxylase, carboxyltransferase, and carboxyl carrier protein components. J Biol Chem. 1974, 249: 6633-6645.
- Nenortas E, Beckett D: Purification and characterization of intact and truncated forms of the Escherichia coli biotin carboxyl carrier subunit of acetyl-CoA carboxylase. J Biol Chem. 1996, 271: 7559-7567. 10.1074/jbc.271.13.7559.View Article
- Li SJ, Cronan JE: The genes encoding the two carboxyltransferase subunits of Escherichia coli acetyl-CoA carboxylase. J Biol Chem. 1992, 267: 16841-16847.
- Taylor AL, Trotter CD: Linkage map of Escherichia coli strain K-12. Bacteriol Rev. 1972, 36: 504-524.
- Booker SJ: Anaerobic functionalization of unactivated C-H bonds. Curr Opin Chem Biol. 2009, 13: 58-73. 10.1016/j.cbpa.2009.02.036.View Article
- Ugulava NB, Sacanell CJ, Jarrett JT: Spectroscopic changes during a single turnover of biotin synthase: destruction of a [2Fe-2S] cluster accompanies sulfur insertion. Biochemistry. 2001, 40: 8352-8358. 10.1021/bi010463x.View Article
- Alberts AW, Nervi AM, Vagelos PR: Acetyl CoA carboxylase, II. Deomonstration of biotin-protein and biotin carboxylase subunits. Proc Natl Acad Sci USA. 1969, 63: 1319-1326. 10.1073/pnas.63.4.1319.View Article
- Nervi AM, Alberts AW, Vagelos PR: Acetyl CoA carboxylase. 3. Purification and properties of a biotin carboxyl carrier protein. Arch Biochem Biophys. 1971, 143: 401-411. 10.1016/0003-9861(71)90227-X.View Article
- Ifuku O, Miyaoka H, Koga N, Kishimoto J, Haze S, Wachi Y, Kajiwara M: Origin of carbon atoms of biotin. 13C-NMR studies on biotin biosynthesis in Escherichia coli. Eur J Biochem. 1994, 220: 585-591. 10.1111/j.1432-1033.1994.tb18659.x.View Article
- Nimura T, Suzuki T, Sahashi Y: Studies on the Formation of Biotin from Desthiobiotin and Sulfate in Saccharomyces Cerevisiae. 3. Isotopic Studies on Biotin Formation from Desthiobiotin and S35-Labelled Sulfate by Washed Cell Suspension of Yeast. J Vitaminol (Kyoto). 1964, 10: 231-236.View Article
- Shimada K: [Attempt to label biotin with sulfur-35 by Aspergillus niger]. Yakugaku Zasshi. 1967, 87: 351-356.
- Izumi Y, Sugisaki K, Tani Y, Ogata K: Incorporation of the sulfur of L-(35S)methionine into the biotin molecule by intact cells of Rhodotorula glutinis. Biochim Biophys Acta. 1973, 304: 887-890.View Article
- Cronan JE: The biotinyl domain of Escherichia coli acetyl-CoA carboxylase. Evidence that the "thumb" structure id essential and that the domain functions as a dimer. J Biol Chem. 2001, 276: 37355-37364. 10.1074/jbc.M106353200.View Article
- Chapman-Smith A, Turner DL, Cronan JE, Morris TW, Wallace JC: Expression, biotinylation and purification of a biotin-domain peptide from the biotin carboxy carrier protein of Escherichia coli acetyl-CoA carboxylase. Biochem J. 1994, 302 (Pt 3): 881-887.View Article
- Fall RR, Vagelos PR: Acetyl coenzyme A carboxylase. Molecular forms and subunit composition of biotin carboxyl carrier protein. J Biol Chem. 1972, 247: 8005-8015.
- Eisenstein E, Beckett D: Dimerization of the Escherichia coli biotin repressor: corepressor function in protein assembly. Biochemistry. 1999, 38: 13077-13084. 10.1021/bi991241q.View Article
- Streaker ED, Beckett D: Coupling of protein assembly and DNA binding: biotin repressor dimerization precedes biotin operator binding. J Mol Biol. 2003, 325: 937-948. 10.1016/S0022-2836(02)01308-6.View Article
- Barker DF, Campbell AM: Genetic and biochemical characterization of the birA gene and its product: evidence for a direct role of biotin holoenzyme synthetase in repression of the biotin operon in Escherichia coli. J Mol Biol. 1981, 146: 469-492. 10.1016/0022-2836(81)90043-7.View Article
- Lotierzo M, Tse Sum Bui B, Florentin D, Escalettes F, Marquet A: Biotin synthase mechanism: an overview. Biochem Soc Trans. 2005, 33: 820-823. 10.1042/BST0330820.View Article
- Jarrett JT: The novel structure and chemistry of iron-sulfur clusters in the adenosylmethionine-dependent radical enzyme biotin synthase. Arch Biochem Biophys. 2005, 433: 312-321. 10.1016/j.abb.2004.10.003.View Article
- Zheng L, Cash VL, Flint DH, Dean DR: Assembly of iron-sulfur clusters. Identification of an iscSUA-hscBA-fdx gene cluster from Azotobacter vinelandii. J Biol Chem. 1998, 273: 13264-13272. 10.1074/jbc.273.21.13264.View Article
- Reyda MR, Fugate CJ, Jarrett JT: A complex between biotin synthase and the iron-sulfur cluster assembly chaperone HscA that enhances in vivo cluster assembly. Biochemistry. 2009, 48: 10782-10792. 10.1021/bi901393t.View Article
- Jojima T, Omumasaba CA, Inui M, Yukawa H: Sugar transporters in efficient utilization of mixed sugar substrates: current knowledge and outlook. Appl Microbiol Biotechnol. 2010, 85: 471-480. 10.1007/s00253-009-2292-1.View Article
- Rasband WS: ImageJ. Book ImageJ. (Editor ed.^eds.). 1997, City: U. S. National Institutes of Health
- Abramoff MD, Magelhaes PJ, Ram SJ: Image Processing with ImageJ. Biophotonics International. 2004, 11: 36-42.
- Datsenko KA, Wanner BL: One-step inactivation of chromosomal genes in Escherichia coli K-12 using PCR products. Proc Natl Acad Sci USA. 2000, 97: 6640-6645. 10.1073/pnas.120163297.View Article
- Baba T, Ara T, Hasegawa M, Takai Y, Okumura Y, Baba M, Datsenko KA, Tomita M, Wanner BL, Mori H: Construction of Escherichia coli K-12 in-frame, single-gene knockout mutants: the Keio collection. Mol Syst Biol. 2006, 2: 10.1038/msb4100050. 2006 0008
- Hwang SY, Su V, Farh L, Shiuan D: Bioassay of biotin concentration with a Escherichia coli bio deletion mutant. J Biochem Biophys Methods. 1999, 39: 111-114. 10.1016/S0165-022X(98)00012-8.View Article
- Athappilly FK, Hendrickson WA: Structure of the biotinyl domain of acetyl-coenzyme A carboxylase determined by MAD phasing. Structure. 1995, 3: 1407-1419. 10.1016/S0969-2126(01)00277-5.View Article
- Johnson DC, Unciuleac MC, Dean DR: Controlled expression and functional analysis of iron-sulfur cluster biosynthetic components within Azotobacter vinelandii. J Bacteriol. 2006, 188: 7551-7561. 10.1128/JB.00596-06.View Article
- Cagnon C, Valverde V, Masson JM: A new family of sugar-inducible expression vectors for Escherichia coli. Protein Eng. 1991, 4: 843-847. 10.1093/protein/4.7.843.View Article
- Kapust RB, Waugh DS: Controlled intracellular processing of fusion proteins by TEV protease. Protein Expr Purif. 2000, 19: 312-318. 10.1006/prep.2000.1251.View Article
- Allary M, Lu JZ, Zhu L, Prigge ST: Scavenging of the cofactor lipoate is essential for the survival of the malaria parasite Plasmodium falciparum. Mol Microbiol. 2007, 63: 1331-1344. 10.1111/j.1365-2958.2007.05592.x.View Article
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.